In the past week, NXTC stock has gone down by -20.11%, with a monthly gain of 4.86% and a quarterly surge of 31.30%. The volatility ratio for the week is 11.74%, and the volatility levels for the last 30 days are 13.26% for Nextcure Inc The simple moving average for the past 20 days is -22.61% for NXTC’s stock, with a 4.13% simple moving average for the past 200 days.
Is It Worth Investing in Nextcure Inc (NASDAQ: NXTC) Right Now?
The 36-month beta value for NXTC is also noteworthy at 0.47. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for NXTC is 21.10M, and at present, short sellers hold a 4.71% of that float. The average trading volume of NXTC on April 18, 2024 was 276.21K shares.
NXTC) stock’s latest price update
Nextcure Inc (NASDAQ: NXTC) has experienced a decline in its stock price by -7.93 compared to its previous closing price of 1.64. However, the company has seen a fall of -20.11% in its stock price over the last five trading days. GlobeNewsWire reported 2024-04-02 that BELTSVILLE, Md., April 02, 2024 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies to treat cancer, today announced that it will present at the 23rd Annual Needham Virtual Healthcare Conference on Thursday, April 11th, at 12:45 pm ET.
Analysts’ Opinion of NXTC
Ladenburg Thalmann, on the other hand, stated in their research note that they expect to see NXTC reach a price target of $16. The rating they have provided for NXTC stocks is “Buy” according to the report published on March 01st, 2022.
Truist gave a rating of “Buy” to NXTC, setting the target price at $19 in the report published on March 05th of the previous year.
NXTC Trading at -11.00% from the 50-Day Moving Average
After a stumble in the market that brought NXTC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -41.25% of loss for the given period.
Volatility was left at 13.26%, however, over the last 30 days, the volatility rate increased by 11.74%, as shares surge +5.59% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +17.97% upper at present.
During the last 5 trading sessions, NXTC fell by -20.11%, which changed the moving average for the period of 200-days by -16.11% in comparison to the 20-day moving average, which settled at $1.9553. In addition, Nextcure Inc saw 32.46% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for NXTC
The total capital return value is set at -0.55. Equity return is now at value -44.49, with -39.81 for asset returns.
Based on Nextcure Inc (NXTC), the company’s capital structure generated 0.05 points at debt to capital in total, while cash flow to debt ratio is standing at -8.02. The debt to equity ratio resting at 0.06. The interest coverage ratio of the stock is 69.37.
Currently, EBITDA for the company is -63.95 million with net debt to EBITDA at 0.1. The liquidity ratio also appears to be rather interesting for investors as it stands at 16.38.
Conclusion
In summary, Nextcure Inc (NXTC) has had a mixed performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
